eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Servier Laboratories Limited

Rowley, Wexham Springs, Framewood Road, Wexham, Slough, SL3 6PJ
Telephone: +44 (0)1753 662744
Fax: +44 (0)1753 663456
Medical Information Direct Line: +44 (0)1753 666409
Medical Information e-mail: medical.information@uk.netgrs.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 14/03/2012
PIL Natrilix

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/03/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to MA holder contact details
Updated on 07/10/2011 and displayed until 14/03/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 27/08/2008 and displayed until 07/10/2011
Reasons for adding or updating:
  • Change to information about driving or using machinery
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about overdose
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to dosage and administration
  • Change due to user-testing of patient information
Updated on 15/06/2007 and displayed until 27/08/2008
Reasons for adding or updating:
  • Change to manufacturer contact details
Updated on 07/01/2004 and displayed until 15/06/2007
Reasons for adding or updating:
  • Update to PIL
Updated on 19/09/2003 and displayed until 07/01/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 05/07/2001 and displayed until 19/09/2003
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   indapamide